Biofrontera (BFRI) Profit After Tax (QoQ) (2020 - 2025)
Biofrontera (BFRI) Profit After Tax (QoQ) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Biofrontera | 10.73 Mn | 4.32 Mn | 14.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 184.82% |
| Sep 30, 2025 | -24.89% |
| Jun 30, 2025 | -26.67% |
| Mar 31, 2025 | -201.07% |
| Dec 31, 2024 | 75.37% |
| Sep 30, 2024 | -2,105.84% |
| Jun 30, 2024 | 97.54% |
| Mar 31, 2024 | -396.00% |
| Dec 31, 2023 | 155.60% |
| Sep 30, 2023 | 35.53% |
| Jun 30, 2023 | -31.55% |
| Mar 31, 2023 | -168.51% |
| Dec 31, 2022 | -8.53% |
| Sep 30, 2022 | -201.88% |
| Jun 30, 2022 | -115.29% |
| Mar 31, 2022 | 138.34% |
| Dec 31, 2021 | 9.41% |
| Sep 30, 2021 | -337.37% |
| Jun 30, 2021 | -3.59% |
| Mar 31, 2021 | -1,675.88% |